Aspire Biopharma (ASBP) Competitors $0.35 +0.03 (+10.10%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock ASBP vs. CLSD, ASRT, OTLK, IRD, IKNA, RPTX, UNCY, PMVP, CNTB, and CRVOShould you be buying Aspire Biopharma stock or one of its competitors? The main competitors of Aspire Biopharma include Clearside Biomedical (CLSD), Assertio (ASRT), Oncobiologics (OTLK), Opus Genetics (IRD), Ikena Oncology (IKNA), Repare Therapeutics (RPTX), Unicycive Therapeutics (UNCY), PMV Pharmaceuticals (PMVP), Connect Biopharma (CNTB), and CervoMed (CRVO). These companies are all part of the "pharmaceutical products" industry. Aspire Biopharma vs. Its Competitors Clearside Biomedical Assertio Oncobiologics Opus Genetics Ikena Oncology Repare Therapeutics Unicycive Therapeutics PMV Pharmaceuticals Connect Biopharma CervoMed Clearside Biomedical (NASDAQ:CLSD) and Aspire Biopharma (NASDAQ:ASBP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations. Which has more volatility and risk, CLSD or ASBP? Clearside Biomedical has a beta of 2.05, indicating that its stock price is 105% more volatile than the S&P 500. Comparatively, Aspire Biopharma has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Is CLSD or ASBP more profitable? Aspire Biopharma has a net margin of 0.00% compared to Clearside Biomedical's net margin of -818.57%. Company Net Margins Return on Equity Return on Assets Clearside Biomedical-818.57% N/A -114.23% Aspire Biopharma N/A N/A -508.70% Does the media refer more to CLSD or ASBP? In the previous week, Clearside Biomedical and Clearside Biomedical both had 1 articles in the media. Clearside Biomedical's average media sentiment score of 1.89 beat Aspire Biopharma's score of 0.43 indicating that Clearside Biomedical is being referred to more favorably in the media. Company Overall Sentiment Clearside Biomedical Very Positive Aspire Biopharma Neutral Which has better valuation & earnings, CLSD or ASBP? Aspire Biopharma has lower revenue, but higher earnings than Clearside Biomedical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearside Biomedical$1.66M39.14-$34.35M-$0.41-2.04Aspire BiopharmaN/AN/A-$12.54MN/AN/A Do institutionals and insiders hold more shares of CLSD or ASBP? 18.8% of Clearside Biomedical shares are owned by institutional investors. Comparatively, 19.2% of Aspire Biopharma shares are owned by institutional investors. 6.2% of Clearside Biomedical shares are owned by company insiders. Comparatively, 48.0% of Aspire Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer CLSD or ASBP? Clearside Biomedical presently has a consensus price target of $4.75, suggesting a potential upside of 468.18%. Given Clearside Biomedical's stronger consensus rating and higher probable upside, analysts clearly believe Clearside Biomedical is more favorable than Aspire Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearside Biomedical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Aspire Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryClearside Biomedical beats Aspire Biopharma on 7 of the 11 factors compared between the two stocks. Get Aspire Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ASBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASBP vs. The Competition Export to ExcelMetricAspire BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.74M$2.91B$5.52B$9.32BDividend YieldN/A2.46%4.25%4.05%P/E RatioN/A20.3628.1519.68Price / SalesN/A304.13438.33100.29Price / CashN/A42.3835.5357.53Price / Book-0.167.768.235.67Net Income-$12.54M-$55.11M$3.23B$257.51M7 Day Performance7.36%0.95%-0.01%0.52%1 Month Performance-0.82%8.44%5.61%8.84%1 Year PerformanceN/A-2.38%26.52%14.18% Aspire Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASBPAspire BiopharmaN/A$0.35+10.1%N/AN/A$15.74MN/A0.00N/AGap UpCLSDClearside Biomedical2.0587 of 5 stars$0.88+1.1%$4.75+436.8%-33.3%$68.03M$1.66M-2.1630Positive NewsASRTAssertio1.8321 of 5 stars$0.69-2.7%$2.75+298.0%-57.1%$68.01M$124.96M-2.1620News CoverageOTLKOncobiologics2.2986 of 5 stars$2.07+2.5%$9.60+363.8%-73.1%$67.81MN/A-2.2720Gap UpIRDOpus Genetics1.8458 of 5 stars$1.13+0.9%$7.33+549.0%N/A$67.42M$13.65M-0.5414IKNAIkena Oncology2.7667 of 5 stars$1.38-0.7%$3.00+117.4%-16.5%$67.08M$9.16M-1.6070News CoverageGap DownRPTXRepare Therapeutics3.0613 of 5 stars$1.50-3.8%$4.50+200.0%-60.3%$66.91M$53.48M-0.50180News CoveragePositive NewsGap UpUNCYUnicycive Therapeutics2.9751 of 5 stars$5.01-4.6%$60.00+1,097.6%-7.4%$66.36M$680K-0.989High Trading VolumePMVPPMV Pharmaceuticals3.1554 of 5 stars$1.26-0.8%$5.50+336.5%-18.4%$65.98MN/A-1.0750Positive NewsCNTBConnect Biopharma3.0914 of 5 stars$1.52+32.2%$7.00+360.5%+15.9%$63.90M$26.03M0.00110Gap UpHigh Trading VolumeCRVOCervoMed3.2802 of 5 stars$7.15-0.8%$22.57+215.7%-59.9%$62.75M$9.74M-3.284News Coverage Related Companies and Tools Related Companies CLSD Alternatives ASRT Alternatives OTLK Alternatives IRD Alternatives IKNA Alternatives RPTX Alternatives UNCY Alternatives PMVP Alternatives CNTB Alternatives CRVO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASBP) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspire Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspire Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
